Phase I/II Study With Lapatinib Plus Trametinib in Patients With Metastatic KRAS Mutant Non-small Cell Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Lapatinib (Primary) ; Trametinib (Primary) ; Capecitabine; Docetaxel; Irinotecan
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms M14LTK
- 08 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
- 10 Nov 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
- 01 May 2012 New trial record